✦ LIBER ✦

Neuroleptic malignant-like syndrome induced by metoclopramide

✍ Scribed by Dr. M. Reza Samie

Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 275 KB
Volume: 2
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.870020108

No coin nor oath required. For personal study only.

✦ Synopsis

A prompt recognition of neuroleptic malignant-like syndrome is essential because of its high morbidity and mortality. A similar condition is described associated with metoclopramide, an agent with dopamine receptorblocking properties. An increased index of suspicion for early diagnosis of this condition and adjustment of metoclopramide dosing in patients with renal failure are emphasized.

📜 SIMILAR VOLUMES

Neuroleptic malignant-like syndrome asso

Neuroleptic malignant-like syndrome associated with acute hydrocephalus

✍ Chin-Song Lu; Shan-Jin Ryu 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 458 KB

Olanzapine induced neuroleptic malignant

Olanzapine induced neuroleptic malignant syndrome—a case review

✍ Aleš Kogoj; Ingrid Velikonja 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

## Abstract Neuroleptic malignant syndrome is the rarest and the most serious of the neuroleptic induced movement disorders. Although potent neuroleptics are more frequently associated with NMS, atypical antipsychotic drugs may also be a cause of NMS. Three databases were searched using the terms ‘

Rhabdomyolysis without neuroleptic malig

Rhabdomyolysis without neuroleptic malignant syndrome induced by additional treatment of risperidone

✍ Norio Yasui; Tsuyoshi Kondo; Koichi Otani; Sunao Kaneko 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

This is the ®rst case report of rhabdomyolysis without neuroleptic malignant syndrome induced by additional treatment of risperidone. The manifestations of this side eect were symptoms of myalgia, muscle weakness and redcoloured urine with ®ndings of markedly elevated levels of creatine kinase and m

Case of neuroleptic malignant-like syndr

Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance

✍ Shafeeq S. Ladha; Russell Walker; Holly A. Shill 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

## Abstract Neuroleptic malignant‐like syndrome (NMLS) is well described in the treatment of Parkinson's disease. The syndrome is characterized by fever, rigidity, autonomic instability, elevated creatine phosphokinase levels, and altered level of consciousness, which is usually precipitated by lev

Neuroleptic malignant like syndrome in t

Neuroleptic malignant like syndrome in two patients on cholinesterase inhibitors

✍ J. B. Grace; P. Thompson 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB

A case of tetrabenazine-induced neurolep

A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment

✍ Giselle M. Petzinger; Susan B. Bressman 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB

We report the case of a patient with tardive dystonia and a history of psychiatric illness who showed signs of neuroleptic malignant syndrome (NMS) after chronic treatment with tetrabenazine. The first symptom was a mental status change 'consisting of confusion, disorganized thinking, paranoid delus